Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Reference Range Harmonization

CDC Hormone Standardization (HoSt) and Harmonized Testosterone Ranges

Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not a product (a laboratory standardization initiative)

Reference only. Not medical advice.

What can go wrong

The clinical risk lies in ignoring standardization: using a non-standardized assay or a lab-specific range can misclassify a man as hypogonadal or normal. Reference ranges also differ by age, time of day, and assay; results should be drawn in the morning, confirmed on a repeat, and interpreted against an appropriate harmonized range with clinical context.

This is something to take to a clinician. The Atlas can tell you what is known about reference range harmonization in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Historically, testosterone assays disagreed substantially between laboratories, so the same blood could yield different numbers and reference ranges. The CDC Hormone Standardization Program (HoSt), launched in 2010, certifies laboratories against an accurate reference method to reduce this variability. Standardization enabled development of harmonized reference ranges: in a pooled analysis of cohorts in the US and Europe, healthy nonobese men aged 19 to 39 had a harmonized normal range with a 2.5th-to-97.5th percentile of roughly 264 to 916 ng/dL.

Making one lab's testosterone number mean the same as another's.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Interpreting testosterone results consistently
  • Comparing values across labs and over time
  • Underpinning evidence-based diagnostic thresholds

How it works

HoSt assesses participating assays against a CDC reference measurement procedure and certifies those meeting a defined accuracy criterion. By anchoring assays to a common standard, the program shrinks inter-laboratory bias, which makes a measured value clinically meaningful regardless of which certified lab ran it and supports a single harmonized reference range rather than dozens of lab-specific ones.

What it does to fertility

Reference harmonization is a measurement standard, not a treatment, so it has no direct fertility effect; its relevance is ensuring that the testosterone values used in fertility and hypogonadism workups are accurate and comparable.

What has to be monitored

The bloodwork this needs, and the reason it belongs with a clinician rather than a website.

  • Use of a CDC-standardized/harmonized assay where possible
  • Morning sampling
  • Repeat confirmation of low values
  • Interpretation against age-appropriate harmonized ranges

What people get wrong

Nothing recorded here yet. There is almost certainly something people get wrong about this one, and the blank space means we have not written it down, not that the record is clean.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

Set against the alternatives

Standardized, harmonized ranges are a major improvement over the era of conflicting lab-specific ranges, and they are now reflected in guideline-based diagnostic thresholds for hypogonadism. Free-testosterone measurement remains less standardized than total testosterone.

At a glance

Program start
CDC HoSt, 2010
Harmonized range (men 19-39)
~264-916 ng/dL (2.5th-97.5th pct)
Why it matters
Lets results and ranges compare across labs

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Reference Range Harmonization. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Harmonized reference ranges for circulating testosterone (Travison et al.)2017

    Pooled four US and European cohorts to derive harmonized normal ranges, reporting roughly 264-916 ng/dL for healthy nonobese men aged 19-39

  • CDC HoSt program reports2010 onward

    Documented marked reductions in inter-laboratory bias for total testosterone after standardization